Aktie A1JSDB PLANDAÍ BIOTECHNOLOGY, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Plandaí Biotechnology, Inc.

Aktien

A1JSDB

US72703D1000

PLPL

Verzögert OTC Markets
Andere Börsenplätze
 17:32:02 21.05.2024 		% 5 Tage % 1. Jan.
0,0006 USD +50,00 % Intraday Chart für Plandaí Biotechnology, Inc. +200,00 % +200,00 %
2023 Plandaí Biotechnology, Inc. hat die Übernahme von ByoPlanet International, LLC abgesagt. CI
2023 Rick O'Shea übernimmt die Rolle des CEO von Plandaí Biotechnology, Inc. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Plandaí Biotechnology, Inc. cancelled the acquisition of ByoPlanet International, LLC.
CapitalGainsReport: Penny Stock Breakout Watchlist (EPAZ, DPLS, PLPL, BDPT)
Sub-Penny Spotlight (HBRM, PLPL, CNNA, AITX)
Plandai Subsidiary ByoPlanet Announces Strategic Distribution Agreement with Merck Animal Health
CapitalGainsReport: News Catalysts Could Send These Stocks Soaring (EPAZ, GGSM, KYNC, PLPL)
Rick O'Shea Steps into the Role as CEO of Plandaí Biotechnology, Inc
Plandaí Biotechnology, Inc. entered into share exchange agreement to acquire ByoPlanet International, LLC.
PLANDAI BIOTECHNOLOGY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
PLANDAI BIOTECHNOLOGY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)
EV Hotel Corp. terminated the acquisition of Plandaí Biotechnology, Inc. in a reverse merger transaction.
EV Hotel Corp. entered into non-binding letter of intent to acquire Plandaf Biotechnology, Inc. in a reverse merger transaction.
Plandaí Biotechnology : Plandai Biotechnology, Inc. Announces Termination of Non-Binding Letter of Intent
Plandaí Biotechnology : SEC Cancels Regulatory Penalty and Interest Concerning Legacy Civil Enforcement Action
Plandaí Biotechnology : Plandai Biotechnology, Inc. Reinstated
Plandai Biotechnology Provides Comment on SEC Action
Plandaí Biotechnology Announces Successful Completion of Government Inspection of Affiliate Protext Pharma’s Proposed Medical Cannabis Facility
Plandai Biotechnology Exploring Opportunities in the U.S. Poultry Market
Plandaí Biotechnology to Focus on International Nutraceutical Cannabis Opportunities
Plandai Biotechnology Discusses Cannabis Extract Opportunities and Research Potential
Plandai Biotechnology Discusses Potential for Using Phytofare in Treating Type II Diabetes
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1JSDB Aktie
  4. Nachrichten Plandaí Biotechnology, Inc.
  5. Andere Sprachen